KRAS mutation testing of colorectal cancer for anti-EGFR therapy: dogmas versus evidence

dc.contributor.author	Tímár, József
dc.contributor.author	Hegedűs, Balázs
dc.contributor.author	Rásó, Erzsébet
dc.date.accessioned	2017-03-29T13:07:00Z
dc.date.available	2017-03-29T13:07:00Z
dc.date.issued	2010
dc.identifier	79958287180
dc.identifier.citation	pagination=813-823; journalVolume=10; journalIssueNumber=8; journalTitle=CURRENT CANCER DRUG TARGETS;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/3496
dc.identifier.uri	doi:10.2174/156800910793357989
dc.relation.ispartof	urn:issn:1568-0096
dc.title	KRAS mutation testing of colorectal cancer for anti-EGFR therapy: dogmas versus evidence
dc.type	Journal Article
dc.date.updated	2016-06-09T11:33:51Z
dc.language.rfc3066	en
dc.identifier.mtmt	1432184
dc.identifier.wos	000285777300003
dc.identifier.pubmed	20718705
dc.contributor.department	SE/AOK/I/II. Sz. Patológiai Intézet
dc.contributor.institution	Semmelweis Egyetem